Table 2. Baseline demographic, clinical, and laboratory data of group A1 and group A2a

Group A1 Transplant Nephrectomy DoneGroup A2 Transplant Nephrectomy not Done
a Data are mean ± SD. ESR, erythrocyte sedimentation rate.
Significance between group A1 and group A2 patients at baseline: b P < 0.01;
c P < 0.05.
N2914
Age (yr)43.8 ± 13.0b59.6 ± 12.3
Gender (% male)58.750
Hb (g/dl)9.8 ± 1.8b11.6 ± 1.5
rHu-EPO dose (U/wk)8448 ± 2599NS9954 ± 6270
ERI (U/kg per wk per g/dl)16.5 ± 7.9NS15.1 ± 11.8
Ferritin (μg/L)594 ± 400c272 ± 259
TSI (%)23.5 ± 8.0NS30.5 ± 12.4
Albumin (g/dl)3.1 ± 0.7NS3.4 ± 0.4
Prealbumin (mg/dl)26.0 ± 13.5NS24.3 ± 10.6
CRP (mg/dl)6.6 ± 5.2c3.1 ± 4.2
Fibrinogen (mg/dl)535.3 ± 218.6NS502.3 ± 196.6
ESR (mm/h)88.4 ± 40.4c48.1 ± 28.7
iPTH (pg/ml)234.9 ± 250.2NS285 ± 302.9